Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of lifitegrast eye drops for dry eye disease
CTR20241873Phase 3Active
- Sponsor
- Chenxin Fodu Pharmaceutical
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lifitegrast in dry eye syndrome (DED), sponsored by Chenxin Fodu Pharmaceutical. Started Jul 2024; status: active.
02
Drugs
lifitegrast
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20241873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241873.